Healthcare Impact Holdings

Healthcare Impact Holdings appears to be a healthcare and life sciences investment vehicle rather than a therapeutic drug developer. Public references indicate it was formed in April 2018 as Healthcare Impact Holdings SPC to support a broad portfolio of global life science investments. Materials associated with the Stetson Family Office and Healthcare Impact Foundation describe the entity as part of an ecosystem focused on prevention, wellness, diagnostics, treatments, and healthcare innovation. There is no clear evidence from publicly accessible sources that the company operates its own clinical-stage drug pipeline. The entity is therefore best characterized as an active healthcare-focused investment holding company with a broad life sciences mandate.